drugset / Trial / NCT07305935

Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury

NCT07305935

Completed 236 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelPrevention

Summary

Recent observational data point towards a reduced incidence of acute kidney injury (AKI) with early caffeine use, but high-quality randomized controlled trials comparing early caffeine initiation to supportive therapy alone are lacking. This study aims to fill this critical gap by comparing the efficacy of early caffeine administration versus supportive therapy in preventing AKI in preterm neonates.

Timeline

Start
2025-10-01
Primary completion
2026-03-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 5 mg/kg Intravenous

Indications

No indication recorded.